BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22307659)

  • 1. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required?
    Zaid AN; Ghoush AA; Al-Ramahi R; Are'r M
    PDA J Pharm Sci Technol; 2012; 66(1):20-7. PubMed ID: 22307659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB; Khan MA; Gupta A; Faustino PJ
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements.
    Zaid AN; Ghosh AA
    Arch Pharm Res; 2011 Jul; 34(7):1183-9. PubMed ID: 21811926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting.
    Helmy SA
    J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight uniformity of scored tablet halves manufactured by palestinian pharmaceutical companies.
    Zaid AN; Abu GA; Kittana N
    Int J Pharm Compd; 2010; 14(3):257-60. PubMed ID: 23965504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight and content uniformity of lorazepam half-tablets: A study of correlation of a low drug content product.
    Zaid AN; Al-Ramahi RJ; Ghoush AA; Qaddumi A; Zaaror YA
    Saudi Pharm J; 2013 Jan; 21(1):71-5. PubMed ID: 23960821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of medication dose uniformity in commonly split tablets.
    Teng J; Song CK; Williams RL; Polli JE
    J Am Pharm Assoc (Wash); 2002; 42(2):195-9. PubMed ID: 11926662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight uniformity of split tablets required by a Veterans Affairs policy.
    Polli JE; Kim S; Martin BR
    J Manag Care Pharm; 2003; 9(5):401-7. PubMed ID: 14613437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of formulation variables on weight uniformity of scored tablets using factorial design.
    Zaid AN; Hawari R; Malkieh N; Natshih Y; Yousef A; Jaradat N; Hammad A; Basharat R
    Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2501-2507. PubMed ID: 31894042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of tablet splitting: Comparison study between hand splitting and tablet cutter.
    Habib WA; Alanizi AS; Abdelhamid MM; Alanizi FK
    Saudi Pharm J; 2014 Nov; 22(5):454-9. PubMed ID: 25473334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight variability of pharmacist-dispensed split tablets.
    Rosenberg JM; Nathan JP; Plakogiannis F
    J Am Pharm Assoc (Wash); 2002; 42(2):200-5. PubMed ID: 11926663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtomographic studies of subdivision of modified-release tablets.
    Wilczyński S; Koprowski R; Duda P; Banyś A; Błońska-Fajfrowska B
    Int J Pharm; 2016 Sep; 511(2):899-912. PubMed ID: 27480395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different splitting techniques on the characteristics of divided tablets of five commonly split drug products in Jordan.
    Gharaibeh SF; Tahaineh L
    Pharm Pract (Granada); 2020; 18(2):1776. PubMed ID: 32377280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice.
    Tahaineh LM; Gharaibeh SF
    J Pharm Pract; 2012 Aug; 25(4):471-6. PubMed ID: 22544621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practices of tablet splitting and dose uniformity of fragments at public hospitals in Ethiopia: A cross-sectional study supported by experimental findings.
    Emagn Kasahun A; Joseph NM; Belete A
    PLoS One; 2022; 17(12):e0279135. PubMed ID: 36520879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of pharmaceutical quality of furosemide tablets from multinational markets.
    Qureshi SA; McGilveray IJ
    Drug Dev Ind Pharm; 1998 Nov; 24(11):995-1005. PubMed ID: 9876554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uniformity of dosage units--comparative study of methods and specifications between Eur. Pharm. 3rd and USP 23.
    Martins JM; Farinha A
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):487-95. PubMed ID: 9919948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.